- Methoxypiperamide
- MEXP
- MeOP
EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Power, JD; Scott, KR; Gardner, EA; McAteer, BMC; O'Brien, JE; Brehon, M; Talbot, B; Kavanagh, PV. The syntheses, characterization and in vitro metabolism of nitracaine, methoxypiperamide and mephtetramine Drug Test. Anal., 1 Jul 2014, 6 (7-8), 668-675. 746 kB. https://doi.org/10.1002/dta.1616 #4 GC,LC,MS,NMR
Kavanagh, PV; Power, JD. New psychoactive substances legislation in Ireland – Perspectives from academia Drug Test. Anal., 1 Jul 2014, 6 (7-8), 884-891. 1.2 MB. https://doi.org/10.1002/dta.1598
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects Forensic Sci. Int., 1 Dec 2020, 317, 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #Methoxypiperamide